Key Events This Week
27 Jul: Stock opens at Rs.278.45, modest gain of 0.94%
28 Jul: Mixed technical signals amid mildly bullish momentum
29 Jul: New 52-week high at Rs.305.55 and strong intraday surge
30 Jul: New 52-week high at Rs.308
31 Jul: Week closes at Rs.297.45, slight pullback of 1.75%
27 July 2026: Steady Start Amid Broad Market Gains
Artemis Medicare Services Ltd began the week on a positive note, closing at Rs.278.45, up 0.94% from the previous Friday’s close of Rs.275.85. This modest gain came alongside a strong Sensex rally of 1.05%, which closed at 36,207.16. The stock’s volume was moderate at 12,408 shares, indicating cautious but steady buying interest. The price remained comfortably above its 52-week low of Rs.202.85, signalling resilience in the hospital sector.
28 July 2026: Mixed Technical Signals Amid Mildly Bullish Momentum
On 28 July, Artemis Medicare’s price slipped slightly to Rs.277.20, down 0.45%, while the Sensex declined marginally by 0.14%. Technical analysis revealed a nuanced picture: the stock’s momentum shifted from bullish to mildly bullish, with weekly MACD and Bollinger Bands supporting near-term strength, but monthly indicators such as MACD and KST showing mild bearishness. The Relative Strength Index (RSI) remained neutral, suggesting consolidation rather than a decisive trend. Volume dropped to 4,347 shares, reflecting subdued trading activity.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
29 July 2026: Breakout with New 52-Week High and Intraday Surge
The stock surged dramatically on 29 July, closing at Rs.299.10, a 7.90% gain on the day, far outpacing the Sensex’s 1.02% rise to 36,524.95. Intraday, Artemis Medicare hit a new 52-week high of Rs.305.55, marking a 10.23% increase from the previous close and outperforming the hospital sector by 7.5%. The stock also recorded an intraday high of Rs.297.5 with an 8.23% surge, just 0.07% shy of its 52-week peak of Rs.297.7. Volume spiked to 119,857 shares, reflecting strong investor interest and momentum.
Technical indicators were overwhelmingly positive on shorter timeframes, with the stock trading above all major moving averages and supported by bullish weekly MACD and Bollinger Bands. However, monthly MACD and KST remained mildly bearish, suggesting some caution for longer-term investors. The company’s Mojo Score stood at 78.0 with a Buy rating, upgraded from Hold in June 2026, reinforcing confidence in the stock’s outlook.
Financially, Artemis Medicare demonstrated robust fundamentals underpinning this rally: a low Debt to EBITDA ratio of 1.39 times, operating profit growth at 59.20% annually, and nine consecutive quarters of positive results. The latest quarter reported net sales of Rs.279.23 crores and PBDIT of Rs.51.60 crores, with an operating profit to interest ratio of 8.10 times. Return on equity was 11.3%, and the price-to-book value stood at 4.7, indicating reasonable valuation relative to peers.
30 July 2026: Momentum Continues with Another 52-Week High
Artemis Medicare Services Ltd extended its gains on 30 July, reaching a new 52-week high of Rs.308 intraday, closing at Rs.302.75, up 1.22%. This marked an 8.64% return over two days, outperforming the sector by 0.79%. The Sensex closed marginally higher at 36,541.96, up 0.05%. The stock remained above all key moving averages, signalling sustained bullish momentum.
Long-term performance metrics remained impressive, with a 25.77% total return over the past year versus a 4.67% decline in the Sensex. The company’s PEG ratio was 3.9, reflecting valuation in line with earnings growth. Technical indicators continued to favour the bulls, with weekly MACD bullish and Bollinger Bands positive, though monthly MACD and KST suggested mild caution. Promoter share pledging at 44.53% remained a risk factor to monitor.
Thinking about Artemis Medicare Services Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this small-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
31 July 2026: Slight Pullback to Close the Week
The week concluded with a minor correction as Artemis Medicare closed at Rs.297.45, down 1.75% from the previous day’s close, while the Sensex gained 0.39% to 36,684.83. Despite this pullback, the stock ended the week with a strong 7.83% gain, significantly outperforming the Sensex’s 2.39% rise. Volume remained healthy at 40,045 shares, indicating sustained investor interest. The slight retreat may reflect short-term profit-taking after the recent rally and new highs.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-07-27 | Rs.278.45 | +0.94% | 36,207.16 | +1.05% |
| 2026-07-28 | Rs.277.20 | -0.45% | 36,155.32 | -0.14% |
| 2026-07-29 | Rs.299.10 | +7.90% | 36,524.95 | +1.02% |
| 2026-07-30 | Rs.302.75 | +1.22% | 36,541.96 | +0.05% |
| 2026-07-31 | Rs.297.45 | -1.75% | 36,684.83 | +0.39% |
Key Takeaways
Artemis Medicare Services Ltd demonstrated robust outperformance relative to the Sensex throughout the week, gaining 7.83% versus the benchmark’s 2.39%. The stock’s multiple new 52-week highs at Rs.305.55 and Rs.308 underscore strong upward momentum and investor enthusiasm within the hospital sector.
Technical indicators largely favoured the bulls on weekly and daily timeframes, supported by bullish MACD, Bollinger Bands, and moving averages. However, mildly bearish monthly signals from MACD and KST, along with Dow Theory’s cautious stance, suggest investors should monitor for potential consolidation or volatility in the medium term.
Financial fundamentals remain a key strength, with impressive operating profit growth, consistent quarterly results, and solid debt servicing metrics. The company’s Mojo Score of 78.0 and Buy rating reflect this positive outlook. Nonetheless, the elevated promoter share pledging at 44.53% represents a risk factor that could impact price stability in adverse market conditions.
Volume trends, particularly the surge on 29 July, confirm strong accumulation and market interest. The slight pullback on the final trading day is consistent with profit-taking after a sharp rally and does not detract from the overall positive weekly performance.
Conclusion
Artemis Medicare Services Ltd’s week was characterised by significant price appreciation, technical momentum upgrades, and new 52-week highs, reflecting a strong growth trajectory within the hospital sector. The stock’s consistent outperformance against the Sensex and sector benchmarks highlights its resilience and appeal to investors seeking exposure to healthcare services.
While short-term technical indicators remain bullish, mixed monthly signals and promoter share pledging warrant cautious monitoring. The company’s solid financials and positive market sentiment provide a strong foundation for continued gains, but investors should remain attentive to broader market developments and confirmatory trend signals.
Overall, Artemis Medicare Services Ltd’s performance this week underscores its position as a compelling small-cap stock with robust fundamentals and technical strength, poised to maintain its upward momentum in a competitive sector environment.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
